By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Bioenvision 

345 Park Avenue
41st Floor
New York  New York  10154-0004  U.S.A.
Phone: 212-750-6700 Fax:


SEARCH JOBS


Industry
Biotechnology

Segment
Gene Therapy





Company News
Genzyme Corporation (GENZ) Withdraws Bioenvision (BIVN)'s European Filing of Evoltra(R) in Elderly AML Patients Will Resubmit With New Data from Ongoing Studies 3/19/2008 11:05:27 AM
Genzyme Corporation (GENZ) Gets Bioenvision (BIVN) for $345 Million 10/23/2007 11:47:02 AM
Delaware Court Approves Bioenvision (BIVN) and Genzyme Corporation (GENZ) Joint Petition Special Meeting to be Reconvened on October 22 10/11/2007 11:24:40 AM
Bioenvision (BIVN) and Genzyme Corporation (GENZ) File Petition in Delaware Court 10/10/2007 10:25:35 AM
Bioenvision (BIVN) and Genzyme Corporation (GENZ) (Jobs) Seek to Reopen Vote on Merger 10/10/2007 7:03:08 AM
Bioenvision (BIVN) Adjourns Special Meeting of Stockholders 10/5/2007 12:21:26 PM
Bioenvision (BIVN) Final Vote to Take Place at October 5 Special Meeting of Stockholders 10/5/2007 10:41:49 AM
Genzyme Corporation (GENZ) Affirms Purchase Price for Bioenvision (BIVN) at $5.60 Per Outstanding Share 9/27/2007 10:57:13 AM
Bioenvision (BIVN) Provides Evoltra┬« (clofarabine) Regulatory Update 8/20/2007 4:29:27 PM
Bioenvision (BIVN) Says Securities Class Action Litigation Without Merit 7/27/2007 11:40:35 AM
12345678910...
//-->